Zelgen(SH:688266) Zheng Quan Ri Bao·2025-09-11 12:38Core Insights - The company Zejing Pharmaceutical announced that it will present clinical research data for its self-developed drugs Alveltamig (code: ZG006) and Nilvanstomig (code: ZG005) at the 28th Annual Academic Conference of the Chinese Society of Clinical Oncology (CSCO) scheduled for September 10-14, 2025 [2] - The announcement indicates that the release of the latest clinical data will not have a significant impact on the company's recent performance [2] - The pharmaceutical industry is characterized by high technology, high risk, and high added value, with long and complex development cycles for drugs, making them susceptible to various uncertainties [2] Company Developments - The company will fulfill its information disclosure obligations based on subsequent developments related to the clinical trials [2] - The timeline for drug development from research, clinical trials, approval, to production is lengthy and involves multiple stages [2]